Michael Haude

Showing 1-20 of 63 articles

Coronary interventions

Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies

Stegehuis VE, Wijntjens GW, Bax M, Meuwissen M, Chamuleau SA, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef T

January 21, 2020 | 10.4244/EIJ-D-19-00774

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Evolving paradigms in valvular heart disease: where should guidelines move?

Baumbach A, Dudek D, Baumgartner H, Windecker S, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00818

Interventions for valvular disease

Coronary sinus to mitral valve annulus topography and response to the percutaneous coronary sinus-based mitral valve contour system

Rottländer D, Schneider T, Degen H, Laufenberg M, Chatrou M, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00054

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Interventions for valvular disease

Coronary Sinus to Mitral Valve Annulus Topography and Response to the Percutaneous Coronary Sinus-Based Mitral Valve Contour System

Rottlaender D, Schneider T, Degen H, Laufenberg M, Chatrou M, Haude M

July 2, 2019 | 10.4244/EIJ-D-19-00054

Coronary interventions

A Randomized, Intercontinental, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with de novo Coronary Artery Lesions BIOFLOW IV – Primary Outcome Target Vessel Failure at 12 Months.

Saito S, Tölg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

June 25, 2019 | 10.4244/EIJ-D-18-01214

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018

Barbato E, Mauri J, Byrne R, Roffi M, Fitzsimons D, Toth G, Capodanno D, Mehilli J, Petronio A, Chieffo A, Vardas P, Naber C, Dudek D, Haude M, Baumbach A

April 16, 2019 | 10.4244/EIJV14I17A297

Coronary interventions

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen EH, Wijns W, Neumann F-J, Eeckhout E, Garcia-Garcia H, Waksman R

February 26, 2019 | 10.4244/EIJ-D-18-01000

Coronary interventions

Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Arrif Nuruddin A, Lee MKY

January 22, 2019 | 10.4244/EIJ-D-18-01058

Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina

Schueler R, Al-Lamee R, Mahfoud F, Capodanno D, Asnag M, Haude M

October 19, 2018 | 10.4244/EIJY18M09_2

Stents and scaffolds

Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds

Joner M, Ruppelt P, Zumstein P, Lapointe-Corriveau C, Leclerc G, Bulin A, Castellanos M, Wittchow E, Haude M, Waksman R

October 12, 2018 | 10.4244/EIJ-D-17-00708

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Barbanti M, Prendergast B, Haude M, Piazza N, Windecker S, Baumbach A, Tamburino C

September 7, 2018 | 10.4244/EIJV14SABA1

Other

Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology

Byrne R, Capodanno D, Mahfoud F, Fajadet J, Windecker S, Jüni P, Baumbach A, Wijns W, Haude M

August 24, 2018 | 10.4244/EIJ-D-18-00481

EAPCI Presidential “criss-cross”

Baumbach A, Haude M

May 20, 2018 | 10.4244/EIJV14I1A7

May in Paris! Join us! EuroPCR 2018

Haude M

April 20, 2018 | 10.4244/EIJV13I17A326

Stents and scaffolds

Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

Chevalier B, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Reith S, de Sousa Almeida M, Campo G, Iniguez A, Onuma Y, Serruys P

January 19, 2018 | 10.4244/EIJ-D-17-00873

Answering the challenges of the New Year – the EAPCI in 2018

Haude M

January 19, 2018 | 10.4244/EIJV13I13A243

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary

Byrne R, Stefanini G, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys P, Windecker S

January 19, 2018 | 10.4244/EIJ20170912-01

The year of memories comes to an end, but the time of achievements continues

Haude M

December 20, 2017 | 10.4244/EIJV13I11A201

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Michael Haude

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke